Genomic and phenotypic characterization of six multidrug-resistant Acinetobacter pittii isolates

Nadya Rakovitsky1, Mor Lurie-Weinberger2, Alona Keren-Paz2

  • 1National Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv, Israel. nadyarak@tlvmc.gov.il.

Scientific Reports
|August 13, 2025
PubMed

Insights

Acinetobacter pittii is an emerging nosocomial pathogen. This study found A. pittii isolates carry carbapenem resistance genes and cause severe infections, highlighting the need for enhanced infection control.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genomics

Background:

  • The Acinetobacter calcoaceticus-baumannii complex causes significant nosocomial infections.
  • Acinetobacter baumannii is globally prevalent, but Acinetobacter pittii is an emerging pathogen within this complex.
  • Clinical Acinetobacter pittii isolates remain undercharacterized.

Purpose of the Study:

  • To investigate the genomic and phenotypic characteristics of clinical Acinetobacter pittii isolates.
  • To assess the virulence and carbapenem resistance potential of Acinetobacter pittii.

Main Methods:

  • Whole genome sequencing and phylogenetic analysis of six clinical Acinetobacter pittii isolates.
  • Phenotypic characterization including antimicrobial resistance profiling, motility, and biofilm production.
  • Plasmid transfer experiments and a Zophobas morio survival model to assess virulence.

Main Results:

  • Isolates were genetically distinct and harbored OXA-type β-lactamase genes, conferring resistance to ceftazidime, ertapenem, and in one case, imipenem and meropenem.
  • Plasmid-mediated transfer of blaOXA-72 conferred carbapenem resistance to a recipient Acinetobacter baumannii strain.
  • Acinetobacter pittii isolates demonstrated variable motility and biofilm production, with one carbapenem-resistant strain exhibiting high virulence in a Zophobas morio model.

Conclusions:

  • Acinetobacter pittii acts as a reservoir for carbapenem resistance genes and can cause severe infections.
  • Enhanced infection control measures for the Acinetobacter calcoaceticus-baumannii complex should explicitly include Acinetobacter pittii.